CRP and bacterial infectious disease with sepsis: In addition, treatment with human CRP prior to pneumococcal challenge has been shown to protect mice from severe pneumococcal bacteremia, and while the exact mechanisms behind the protection are not known, it is thought to be related to complement activation [143–147].